GlobeNewswire
-
Treace Announces First Surgical Cases with the SuperBite™ Compression Screw System
07/04/2026 -
Lumin Health Appoints Matthew Mosquera, MD, MS, as Regional Medical Director and Site Director of Lumin Cambridge
07/04/2026 -
PathAI and MedStar Health Announce Partnership to Deploy the AISight® Dx Digital Pathology Platform and Advanced AI Applications
07/04/2026 -
Death by a Thousand Vendors: 81% of Employers Are Hiring Just to Keep Up with Digital Health Vendor Sprawl
07/04/2026 -
Outlook Therapeutics Announces Formal Dispute Resolution Request for ONS-5010/LYTENAVA™ (bevacizumab-vikg) Accepted by FDA
07/04/2026 -
Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners
07/04/2026 -
Moleculin Releases Next CEO Corner Segment Highlighting Annamycin’s Non-Cardiotoxic Profile
07/04/2026 -
20/20 BioLabs Selected by Evexia Diagnostics to Offer OneTest™ for Cancer Through Evexia Platform
07/04/2026 -
Xenon to Highlight Phase 3 X-TOLE2 & Long-Term Data for Azetukalner in Focal Onset Seizures at 2026 AAN Annual Meeting
07/04/2026 -
Abeona Therapeutics® Announces Appointment of Keith A. Goldan to its Board of Directors
07/04/2026 -
Clover Health Empowers Members to Take Charge of Their Health Data Through HealthEx Partnership
07/04/2026 -
Greenwich LifeSciences Provides Update on Patent Claims Potentially Doubling GP2 Market Potential
07/04/2026 -
AscellaHealth Named to Financial Times Americas’ Fastest Growing Companies 2026 List
07/04/2026 -
Serina Therapeutics to Present at the 5th LNP Formulation & Process Development Summit
07/04/2026 -
Virbac : Declaration of the number of shares and voting rights 03/2026
07/04/2026 -
Virbac : Déclaration d'actions et de droits de votes 03/2026
07/04/2026 -
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
07/04/2026 -
Transactions in connection with share buy-back program
07/04/2026 -
Oculis to Participate in Upcoming Investor Conferences
07/04/2026
Pages